MiNK Therapeutics Inc

MiNK Therapeutics sees a leadership refresh with Austin Charette’s appointment while insiders trim holdings, signaling confidence in its pipeline and potential cost‑saving gains.

Insider sales of MiNK Therapeutics’ shares hint at a cautious outlook, even as the company’s pediatric cell‑therapy partnership fuels upside potential.